Last week, Zimbabwe introduced Cabotegravir long-acting (CAB-LA), an injectable pre-exposure prophylaxis (PrEP) drug, as part of its HIV prevention efforts. Zimbabwe Introduces HIV Prevention Drug This drug, designed to suppress HIV infection as it occurs, targets HIV-negative individuals at high […]